September 21, 2014 1:21 PM ET

Capital Markets

Company Overview of Vanguard Specialized Funds - Vanguard REIT ETF

Executive Profile

Edward P. Owens CFA

Director and Member of Governance & Nominating Committee, Ironwood Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 2 Board Members in 2 different organizations across 5 different industries.

See Board Relationships
67$124,495

Background

Mr. Edward P. Owens, also known as Ed, CFA, served as a Partner, Senior Vice President, Portfolio Manager, and Global Industry Analyst at Wellington Management Company, LLP until December 2012. Mr. Owens joined Wellington Management Company, LLP in 1974 as a Healthcare Analyst. He served as Partner, Senior Vice President, Portfolio Manager, and Global Industry Analyst of Astra Funds - Astra Renaissance Global Health Care Fund and Vanguard Health Care Fund; Ecoflex Investment ...

Corporate Headquarters

100 Vanguard Boulevard
Malvern, Pennsylvania 19355

United States

Phone: 610-669-1000
Fax: 610-669-6600

Board Members Memberships

2013-Present
Director and Member of Governance & Nominating Committee
2013-Present
Trustee

Education

MBA
Harvard Business School
BS
University of Virginia

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

Total Calculated Compensation$124,495
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Michael W. Aguiar Chief Executive Officer, President, Chief Financial Officer, Principal Accounting Officer, Senior Vice President of Finance, Treasurer and Director
Theravance Inc.
$515.4K
Howard W. Robin Chief Executive Officer, President and Director
Nektar Therapeutics
$831.2K
Mark R. Baker J.D.Chief Executive Officer, Director and Member of Science & Strategy Committee
Progenics Pharmaceuticals, Inc.
$535.6K
Peter S. Greenleaf Chief Executive Officer, Director, Member of Commercialization Committee and Member of Science & Technology Committee
Sucampo Pharmaceuticals, Inc.
--
A. J. Kazimi MBAFounder, Chairman, Chief Executive Officer and President
Cumberland Pharmaceuticals, Inc.
$620.0K
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Vanguard Specialized Funds - Vanguard REIT ETF, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.